Are markers of proliferation valuable in the histological assessment of pituitary tumours?
about
Best Practice No 172: pituitary gland pathologyApoptosis is increased and cell proliferation is decreased in out-of-phase endometria from infertile and recurrent abortion patientsAltered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.Pituitary carcinoma diagnosed on fine needle aspiration: Report of a case and review of pathogenesis.Aggressive pituitary adenomas--diagnosis and emerging treatments.Update on prognostic factors in acromegaly: Is a risk score possible?A case report of feline pituitary carcinoma with hypercortisolism.A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.Mdm2 and the p53 pathway in human pituitary adenomas.Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion.Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients.Pituitary function and morphology in Fabry disease.Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study
P2860
Q24672859-A8E9AC05-5D39-4F97-8842-FE5E2EF33EE4Q34331811-E9F3AFF5-5634-4389-92D7-617E4A1C60CDQ37060959-0F079655-EDA6-4531-A27F-0F5B3E101698Q37367647-CB72A2F8-2D25-4AA9-B20E-848D82D325D8Q37784148-BC887BAD-0BCC-48E6-809B-E9FB13FCE7B6Q38211375-27823247-98FA-447E-AC66-4C7C6636EFEEQ38214473-4045DCF6-218D-47B5-9878-90F655FB537DQ38664203-58CE5262-9D30-4C0A-B913-92A30BB3E858Q38929926-F7A7A385-369B-476B-962C-E4B59526D0E8Q43202365-40E58E91-2917-4544-8238-9EA5ECE641F4Q48921641-01C53737-1A3A-4E91-8017-B2B7EC9B13CEQ50513833-6A6439DE-531E-4D8E-A582-A746758555C9Q50764305-B612813A-205C-445A-9550-26C6B7F8B01DQ53535649-4979BCFB-81C8-417A-AC4E-A4BE316B1542Q54580353-471B00DA-39BB-4A8D-8D54-C9EECFBFC9B0Q58678745-626419CB-6C8E-4902-BF3A-8EF177DF0B7F
P2860
Are markers of proliferation valuable in the histological assessment of pituitary tumours?
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Are markers of proliferation v ...... sessment of pituitary tumours?
@ast
Are markers of proliferation v ...... sessment of pituitary tumours?
@en
Are markers of proliferation v ...... sessment of pituitary tumours?
@nl
type
label
Are markers of proliferation v ...... sessment of pituitary tumours?
@ast
Are markers of proliferation v ...... sessment of pituitary tumours?
@en
Are markers of proliferation v ...... sessment of pituitary tumours?
@nl
prefLabel
Are markers of proliferation v ...... sessment of pituitary tumours?
@ast
Are markers of proliferation v ...... sessment of pituitary tumours?
@en
Are markers of proliferation v ...... sessment of pituitary tumours?
@nl
P356
P1433
P1476
Are markers of proliferation v ...... sessment of pituitary tumours?
@en
P2093
P2888
P304
P356
10.1023/A:1009979128608
P577
1999-05-01T00:00:00Z
P6179
1017541563